Global Meningococcal Vaccines Market COVID-19 is Impact Analysis, With Sales Volume, Revenue, Market Share, Price, Growth Rate by 2026
Pune, Maharashtra, India, November 20 2020 (Wiredrelease) Allied Analytics –:Global Meningococcal Vaccine Industry garnered $1.93 billion in 2018, and is projected to garner $4.19 billion by 2026, witnessing a CAGR of 9.5% from 2019 to 2026. The report provides a detailed analysis of the top investment pockets, top winning strategies, drivers & opportunities, market size & estimations, competitive landscape, and changing market trends.
Rise in outbreaks of meningococcal disease, increase in immunization programs across the world, and surge in research and development for vaccine technology drive the global meningococcal vaccine market
This report contains a thorough analysis of the pre and post pandemic market scenarios. This report covers all the recent development and changes recorded during the COVID-19 outbreak
Request Free Sample Report at: https://www.alliedmarketresearch.com/request-sample/330
Due to lockdown, immunization programs will come to a halt and program schedules will be changed in various countries.
Research and development activities for vaccine technology will be limited, as researchers need to stay at home during the lockdown.
Meningococcal vaccine is used as a placebo effect in the Covid-19 vaccine trial conducted at the University of Oxford.
Get detailed COVID-19 impact analysis on the Meningococcal Vaccine Market @ https://www.alliedmarketresearch.com/request-for-customization/330?reqfor=covid
Based on vaccine serotype, the majority of share was contributed by MenACWY vaccine segment. It accounted for nearly half of the total share in 2018, and is estimated to maintain its lead position during the forecast period. However, the MenA vaccine segment is anticipated to grow at the highest CAGR of 13.5% during the forecast period.
The conjugate segment to maintain its lead by 2026
Based on vaccine type, the conjugate segment held the largest share of the global meningococcal vaccine market, accounting for nearly half of the total market share in 2018, and is estimated to maintain its lead by 2026. Moreover, this segment is estimated to grow at the highest CAGR of 10.2% from 2019 to 2026. This is attributed to usage of vaccines in routine immunization schedules, preventive campaigns, and outbreak responses. The research also analyzes segments including polysachharide and subcapsular.
North America to maintain its dominance throughout the forecast period
Based on region, North America accounted for the largest market share in terms of revenue in 2018, holding nearly half of the global meningococcal vaccine market, and is estimated to maintain its lead position throughout the forecast period. This is due to surge in prevalence of meningitis disease and ease in availability of meningococcal vaccine products for treatment of the disease. However, Asia-Pacific is expected to portray the largest CAGR of 14.7% from 2019 to 2026, owing to surge in outbreaks of meningococcal diseases and widespread availability of products.
For Purchase Enquiry @ https://www.alliedmarketresearch.com/purchase-enquiry/330
Leading market players
Incepta Pharmaceuticals Ltd., Bio-Manguinhos, Pfizer Inc., Bio-Med Pvt. Limited, Sanofi S.A., Chongqing Zhifei Biological Products Co., Ltd., Serum Institute of India Pvt. Ltd., GlaxoSmithKline Plc., Walvax Biotechnology Co., Ltd., and Hualan Biological Engineering Inc.
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
Avenue Library Subscription | Request for 14 days free trial of before buying: https://www.alliedmarketresearch.com/avenue/trial/starter
5933 NE Win Sivers Drive
#205, Portland, OR 97220
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
This content has been published by Allied Analytics company. The WiredRelease News Department was not involved in the creation of this content. For press release service enquiry, please reach us at firstname.lastname@example.org.